Tower Research Capital LLC (Trc) Avidity Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,029 shares of RNA stock, worth $756,923. This represents 0.02% of its overall portfolio holdings.
Number of Shares
26,029
Previous 1,214
2044.07%
Holding current value
$756,923
Previous $55,000
1274.55%
% of portfolio
0.02%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$321 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$251 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$236 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$231 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...